Novo Nordisk (NVON) Q3 2023 Earnings Report
1 Followers
MX:NVON Q3 2023 EPS Results
- Actual EPS
- MXN 13.19
- Consensus EPS
- MXN 12.62
- Beat/Miss
- Beat by +MXN 0.58
- One Year Ago EPS
- MXN 7.79
MX:NVON Q3 2023 Revenue Results
- Actual Revenue
- MXN 159.08B
- Expected Revenue
- MXN 151.63B
- Beat/Miss
- Beat by +MXN 7.44B
- YoY Revenue Growth
- +38.95%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/02/2023
- Time
- Before Open
- Conference Call
- Thursday, November 2, 2023
MX:NVON Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
MX:NVON Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVON Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.40- | 17.7 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.5616.14 | 12.84 | 25.72% (+3.30) | |
| Aug 04, 2026 | 2026 (Q2) | 14.2917.72 | 17.24 | 2.80% (+0.48) | |
| May 06, 2026 | 2026 (Q1) | 16.4019.35 | 18.46 | 4.82% (+0.89) | |
| Feb 04, 2026 | 2025 (Q4) | 17.1317.70 | 16.44 | 7.67% (+1.26) | |
| Nov 05, 2025 | 2025 (Q3) | 14.1812.84 | 16.35 | -21.45% (-3.51) | |
| Aug 06, 2025 | 2025 (Q2) | 17.0517.24 | 12.21 | 41.19% (+5.03) | |
| May 07, 2025 | 2025 (Q1) | 16.9818.46 | 15.1 | 22.24% (+3.36) | |
| Feb 05, 2025 | 2024 (Q4) | 15.4216.44 | 13.29 | 23.74% (+3.15) | |
| Nov 06, 2024 | 2024 (Q3) | 16.3316.35 | 13.19 | 23.91% (+3.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
